Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 23, 2025Arab Journal of UrologyOpen Access

Double versus standard dose of tamsulosin with solifenacin for management of ureteral stent related symptoms

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAhmed S El HefnawyAin Shams UniversityMRMohamed RamadanAssiut UniversityHAHisham ArafaAin Shams University

Discussion

Loading...

Member takes

Implication

Observational analysis compares double dosing of tamsulosin and solifenacin in managing stent-related symptoms, suggesting improved patient outcomes.

Key Points

  • Double dosing tamsulosin showed enhanced relief of stent-related symptoms compared to standard dosing, improving patient comfort significantly.
  • The primary measure indicated that patients on the double dose experienced a reduction in symptoms, with improvement rates surpassing 50%.
  • Assessment involved a randomized, controlled trial to evaluate symptom management in patients with ureteral stents using tamsulosin and solifenacin.
  • The findings may highlight the need for re-evaluation of dosing strategies in pharmacological treatments for ureteral stent discomfort.

Cite This Study

Hefnawy et al. (2025) studied this question.

synapsesocial.com/papers/68d4757f31b076d99fa6cce6https://doi.org/10.1080/20905998.2025.2561225
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention2024 · 5 citations
  2. 2Indwelling Ureteral Stents: Impact of Material and Shape on Patient Comfort1993 · 129 citations
  3. 3Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III Trial1998 · 169 citations